Abstract

 ' Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. People with psychoses lose touch with reality. Two of the main symptoms are delusions and hallucinations. Antipsychotic drug treatment is a key component of schizophrenia treatment. First-generation antipsychotics, known as typical antipsychotics, neuroleptics or major tranquilizers. Most second-generation drugs, known as atypical antipsychotics, have been developed more recently. All psychotropic medications have the potential to induce numerous and diverse unwanted ocular effects. Psychiatrists, ophthalmologists and patients need to be aware of and prepared for any medication-induced toxic effect. Early prevention and intervention can avoid most of the serious and potentially irreversible ocular toxicities.

 ' The aims of the present study were to assess the occurrence of toxic ocular effects of antipsychotic drugs, evaluate intraocular pressure of chronic psychotic patients treated with psychiatric medications, Correlate toxic ocular effects in patients treated with a variety of antipsychotics to duration of treatment and detect early toxic ocular effects for early intervention. Informed consent will be taken from patients. The present study was conducted on 100 chronic psychotic patients attending the Alexandria main university hospital who on treatment of antipsychotic drugs for a period more than six months period with age group between18 - 60 years.14% of those patients were on typical therapy alone,16% on atypical antipsychotic alone while 70% were on combined therapy. 2% of all cases had pigmentation of conjunctiva all were on typical therapy. Corneal opacity was manifested on 4% of all cases. All of them was on typical therapy. As regard lens opacity, 7% was suffered from lens opacity, six cases due to typical therapy while one cases due to atypical therapy. intraocular pressure was manifested in 11% of all cases. Optic examination revealed two cases had increased cup disc ratio who on typical therapy alone. So, it was concluded that ocular toxicity was manifested mainly with typical therapy that affected by duration of treatment. the incidence of toxicity decreased with atypical or combination of typical and atypical.

Keywords: Pattern of Ocular; Toxicity in Patients; Antipsychotic; Therapy at Alexandria

References

1. Brunton L and Chabner B. “Goodman and Gilman's The Pharmacological Basis of Therapeutics”. 12^th edition. Newyork: McGraw-Hill Education (2011): 417.
2. Lisa H., et al. "Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis". Annals of Internal Medicine (2012).
3. King C and Voruganti LN. “What's in a name? The evolution of the nomenclature of antipsychotic drugs”. Psychiatry and Neuroscience 27.3 (2002): 168-175.
4. Hippius. “The history perspective of clozapine”. Psychopharmacology 99.1 (1989): 3-5.
5. Hoffman RS., et al. “Manual of toxicologic emergencies”. 9^th edition. New York: The McGraw-Hill Companies (2007): 588-589.
6. Tripathi BJ. “Drug induced ocular disorders”. Drug Safety 31.2 (2008): 127-141.
7. Sami Richa and Jean-Claude Yazbek. “Ocular Adverse Effects of Common Psychotropic Agents article review”. CNS Drugs 24.6 (2010): 501-526. 
8. Trudie S. “Anti-Psychotic Agents Related Ocular Toxicity”. Medicine 95.15 (2016): 3. 
9. Kanski JJ. “Clinical ophthalmology”. 5^th editon. Oxford (UK): Butterworth-Heinemann (2006).
10. World Health Organisation. "Mental disorders Fact sheet N°396"(Data base on the internet). (2014). 
11. Helo A., et al. “The maturation of eye movement behavior: Scene viewing characteristics in children and adults”. Vision Research 103 (2014): 83-91.
12. Sönmez İ and Aykan Ü. “Psychotropic Drugs and Ocular Side Effects”. Turkish Journal of Ophthalmology 43.4 (2013): 270-278.
13. Carmona R and Prince K. “Trauma and forensic medicine”. Journal of Trauma 29.9 (1989):1222-1225.
14. Souza VB., et al. “Intraocular pressure in schizophrenic patients treated with psychiatric medications”. Arquivos Brasileiros de Oftalmologia 71.5 (2008): 660-664.
15. Grover S and Avasthi A. “Anti-psychotic prescription pattern: a preliminary survey of Psychiatrists in India”. Indian Journal of Psychiatry 52.3 (2010): 257-259.
16. Gowda GS., et al. “Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series”. Asian Journal of Psychiatry 25 (2017):188-190.
17. Raizman MB., et al. “Drug-Induced Corneal Epithelial changes”. Survey of Ophthalmology 62.3 (2016): 286-301.
18. Divakaran A., et al. “Chlorpromazine induced cataract in a young patient with schizophrenia”. Indian Journal of Psychological Medicine 32 (2010): 69-70.
19. Pakzad-Vaezi KL., et al. “The Association between Cataract Surgery and Atypical Antipsychotic Use: ANested Case-Control Study”. American Journal of Ophthalmology 156.6 (2013): 1141-1146.
20. Bitterman RA. “Medicolegal and Risk Management”. In: John, Marx, Robert, Hockberger, Ron, Walls. Rosen's Emergency Medicine: Concepts and Clinical Practice. 5^th edition. USA: Mosby (2002): 2747-2760. 
21. Morley J., et al. “Peripheral Vascular Injuries”. Emedicine (2007). 
22. Vivekanandan S and Lou MF. “Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens”. Current Eye Research 8.1 (1989): 101-111.
23. Boerrigter RM., et al. “Serotonin (5-HT) and the rat’s eye: some pilot studies”. Documenta Ophthalmologica 82.1-2 (1992): 141-150.
24. Gin-Shaw SL and Jorden RC. “Multiple Trama”. In: John, Marx, Robert, Hockberger, Ron, Walls. Rosen's Emergency Medicine: Concepts and Clinical Practice. Fifth edition. USA: Mosby (2002): 242-255.
25. Hyams AL., et al. “Practice guidelines and malpractice litigation: a two-way street”. Annals of Internal Medicine 122.6 (1995): 450-455.
26. Zimmerman TJ and Wheeler TM. “Miotics: side effects and ways to avoid them”. Ophthalmology 89.1 (1982): 76-80. 
27. Uchio E and Miyakawa K. “Systemic and local Immunological features of atopic dermatitis patients with ocular complications”. British Journal of Ophthalmology 82.1 (1998): 82-87.
28. Lin TH and Chen IJ. “Hypotensive intraocular pressure activity of clozapine and sulpiride (2007). 
29. J Coutinho., et al. “Cup to disc ratio (CDR) In patients with schizophrenia a preliminary cross-sectional study”. German Journal of Psychiatry 11.2 (2008).

Citation

Citation: Wafaa Mohamed El Sehly., et al. “Pattern of Ocular Toxicity in Patients on Antipsychotic Drug Therapy at Alexandria Main University Hospital". Acta Scientific Medical Sciences 4.4 (2020): 69-77.

Copyright

Copyright: © 2020 Wafaa Mohamed El Sehly., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.